Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients.
Wafa A AlsofianiBandar H AlessaFahad AlsabaanAbdullah U AlthemeryAliah M GhithAbdullah A AlfaifiPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2022)
The frequency of DKA episodes was not affected by changing the treatment to ultra-long-acting insulin. Moreover, the results suggest that insulin dosage and types are not the only cause of uncontrolled diabetes. Additional efforts should be made to cover all factors affecting diabetes complication control.